Slide 1: Wound Management Technologies, Inc.
ee EC Oroels INC. “The clinical results we have observed have validated the science behind the product. | would highly recommend CellerateRX® to any conscientious wound Caller eat care provider.” Cellerate, Desmond P. Bell, Jr. DPM Collen ee ee President and Co-Founder "Save A Leg, Save A Life" Foun
Slide 2: Safe Harbor Statement
Safe Harbor Statement mon) ‘Statements in this Presentation are made as of the date of this Presentation unless ‘stated otherwise and are subject to change, completion, or amendment without notice. Neither the delivery of this Presentation at any time shall under any circumstances create an implicat
Slide 3: WFLA TV
Slide 4: Company Highlights
Company Highlights woul) > FDA cleared CellerateRX® wound care products entering the $5B worldwide market > Market and clinical validations > Cost effective with broad uses > Performance advantages over competition > Patented » Active product development pipeline > Resorbable Orthopedic Products > S
Slide 5: CellerateRX Features
WNDM By CellerateRX® Features > CellerateRX® powder and gel is a unique, patented, Activated Collagen > Cost-effective > Biocompatible and biodegradable > Unprecedented range of use in every wound phase and state > Easy to use > Reduces Pain Copyright
Slide 6: Financial Highlights & Projections
Financial Highlights & Projections won) 14,000,000 12,000,000 10,000,000 8,000,000 6,000,000 4,000,000 2,000,000 Oo} -2,000,000 -4,000,000 *6,000,000 T“soa8 2010 [Revenue | 288,021 910,420 Net income (2,302,527) | (5,135,491) Revenue Net Income 2o1e 6,000,000 4,400,000 2012e 12,000,000 4,500,000
Slide 7: CellerateRX Regulatory Status
WNDM By CellerateRX® Regulatory Status > FDA cleared for all wounds* including: Pressure Ulcers (stage !~1V) Diabetic Ulcers Venous Stasis Ulcers ‘Traumatic Wounds Surgical 1% & 24 Degree Burns Ulcers due to Arterial Insufficiency ‘Superficial Wounds (including skin tears) “Except 3rd degree burns >
Slide 8: Evidence Based Studies Verify Efficacy
WNDM By Evidence Based Studies Verify Efficacy PODIATRY ANAGEMENT Clinical Symposium on Ge SKINS varesincone WOUND CARE Calla and isicr @ Sex + Dr. Gary Rothenberg, DPM, CDE, CWS + Gregory B. Pott PhD, K. Scott Beard MS, (Miami VA) Matthew Regulski, DPM and Leland + Dr. Jane Fore, MD, FAPWCA, ‘Shapi
Slide 9: Major Deals & Opportunities Forecast Areas of Distribution Focus
WNDM By Major Deals & Opportunities Forecast 5 Areas of Distribution Focus > TV / Retail Distributors > Government Initiatives > Major healthcare systems > Strategic Channel Partners > International
Slide 10: Resorbable Orthopedic Products
WNDM By RESORBABLE ORTHOPEDIC PRODUCTS, LLC Resorbable Bone Wax & Bone Void Filler products > $1.4B Worldwide Bio Materials Market Biotech Pipeline > Resorbable orthopedic hemostat used to stop blood flow & delivery system for osteogenic / osteoinductive orthopedic products > Premarket studies in pr
Slide 11: Secure eHealth
Secure wou @Heaith.. » Secure eHealth technology was featured as part of the Interoperability Showcase at ... e ANNUAL CONFERENCE & EXHIBITION February 20th~ 24", 2011 - Orlando, FL > Weare now using that integration platform as part of a statewide clinical messaging application in 2 states and ina
Slide 12: Company Websites
Company Websites — opt-in fornews “"™ S www.CellerateRX.com www.wmgtech.com ‘www.SecureeHealth.com
Slide 13: Stock Overview
Slide 14: Management
WNDM Management > Scott Haire, Chairman, CEO/CFO > Former President of Preferred Payment Systems > Former CEO of Medbanc Data Corporation. > Deborah Jenkins Hutchinson, President, Director > Former President of Healthcare Computer Corporation v Former President of pH Solutions, Ltd. y Former member
Slide 15: Management, continued
WNDM By Management, continued > Robert Tapales, President of Secure eHealth, LLC Division > 20 years in health management > Former EVP for VirtualHealth Technologies, Inc. > Barry Constantine, Project Consultant, Quality Manager, Lead for Resorbable Orthopedic Products Author / co-author of scientif
Slide 16: Wound Management Technologies, Inc.
WNDM By A |Wound Management QS J TECHNOLOGIES, INC. 777 Main Street, Suite 3100 Fort Worth, Texas 76102 USA +1 (817) 820-7077 Corporate www.wmetech.com 4 Subscribe to our Newsfeed www.CellerateRX.com Deborah Jenkins Hutchinson djenkins@wmgtech.com